{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:34:54Z","timestamp":1791153294951,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107524","type":"journal-article","created":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T18:19:32Z","timestamp":1410545972000},"page":"e107524","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Novel Mucosal DNA-MVA HIV Vaccination in Which DNA-IL-12 Plus Cholera Toxin B Subunit (CTB) Cooperates to Enhance Cellular Systemic and Mucosal Genital Tract Immunity"],"prefix":"10.1371","volume":"9","author":[{"given":"Cynthia","family":"Maeto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda P\u00eda","family":"Holgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Falivene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Magdalena","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri1706","article-title":"Perils at mucosal front lines for HIV and SIV and their hosts","volume":"5","author":"AT Haase","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature08757","article-title":"Targeting early infection to prevent HIV-1 mucosal transmission","volume":"464","author":"AT Haase","year":"2010","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/S0264-410X(00)00481-3","article-title":"Vaccines and mucosal immunisation","volume":"19","author":"AW Cripps","year":"2001","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"PL Ogra","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.4049\/jimmunol.172.10.6209","article-title":"Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule","volume":"172","author":"MM Gherardi","year":"2004","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.172.6.3745","article-title":"Control of simian\/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates","volume":"172","author":"FM Bertley","year":"2004","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/mi.2009.103","article-title":"Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination","volume":"2","author":"M Manrique","year":"2009","journal-title":"Mucosal Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"N Lycke","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.1002594","article-title":"Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA\/recombinant modified vaccinia virus Ankara","volume":"186","author":"M Manrique","year":"2011","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1099\/vir.0.81181-0","article-title":"Recombinant poxviruses as mucosal vaccine vectors","volume":"86","author":"MM Gherardi","year":"2005","journal-title":"J Gen Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.f.1774","article-title":"CD8+ T cell efficacy in vaccination and disease","volume":"14","author":"V Appay","year":"2008","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1128\/JVI.74.14.6278-6286.2000","article-title":"Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime\/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide","volume":"74","author":"MM Gherardi","year":"2000","journal-title":"J Virol"},{"key":"ref13","first-page":"655","article-title":"Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens","volume":"16","author":"MM Gherardi","year":"2001","journal-title":"Histology and histopathology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1128\/JVI.05060-11","article-title":"Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen","volume":"85","author":"N Winstone","year":"2011","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0264-410X(98)00157-1","article-title":"Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery","volume":"17","author":"BP Arulanandam","year":"1999","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.vaccine.2008.06.058","article-title":"Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection","volume":"26","author":"AK Wright","year":"2008","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1128\/JVI.77.10.5589-5597.2003","article-title":"Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins","volume":"77","author":"DI Albu","year":"2003","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","article-title":"Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage","volume":"72","author":"S Andre","year":"1998","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1286-4579(02)00077-1","article-title":"The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36\/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36\/LACK","volume":"5","author":"E Tapia","year":"2003","journal-title":"Microbes Infect"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1128\/JVI.74.16.7651-7655.2000","article-title":"Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector","volume":"74","author":"JC Ramirez","year":"2000","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine","volume":"74","author":"JC Ramirez","year":"2000","journal-title":"Journal of virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0042-6822(87)90480-6","article-title":"Isolation and characterization of attenuated mutants of vaccinia virus","volume":"159","author":"S Dallo","year":"1987","journal-title":"Virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/314445","article-title":"Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract","volume":"178","author":"B Ferko","year":"1998","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/eji.1830231109","article-title":"An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein","volume":"23","author":"C Bergmann","year":"1993","journal-title":"Eur J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2009.08.004","article-title":"Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B","volume":"146","author":"AM Rodriguez","year":"2009","journal-title":"Virus Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover","volume":"204","author":"JR Almeida","year":"2007","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"MR Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e37801","DOI":"10.1371\/journal.pone.0037801","article-title":"IL-12 and GM-CSF in DNA\/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality","volume":"7","author":"AM Rodriguez","year":"2012","journal-title":"PloS one"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.168.2.834","article-title":"Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1","volume":"168","author":"RM Coles","year":"2002","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Durward M, Harms J, Splitter G (2010) Antigen specific killing assay using CFSE labeled target cells. J Vis Exp.","DOI":"10.3791\/2250"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1128\/JVI.00138-10","article-title":"Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime\/boost vaccination","volume":"84","author":"SA Freel","year":"2010","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1128\/JVI.00865-13","article-title":"Early Gag immunodominance of the HIV-specific T-cell response during acute\/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment","volume":"87","author":"G Turk","year":"2013","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1000780","DOI":"10.1371\/journal.ppat.1000780","article-title":"HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity","volume":"6","author":"B Vingert","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1128\/JVI.00460-11","article-title":"High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control","volume":"85","author":"CT Berger","year":"2011","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/erv.11.98","article-title":"Protecting the initial site of viral entry: an alternative HIV vaccine target","volume":"10","author":"L Lopalco","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"J Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.176.5.2749","article-title":"Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin","volume":"176","author":"C Luci","year":"2006","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1016\/j.vaccine.2010.06.033","article-title":"Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract","volume":"28","author":"C Hervouet","year":"2010","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2006.03.045","article-title":"Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649\u2013684), a mucosal subunit HIV\/AIDS vaccine candidate","volume":"24","author":"N Matoba","year":"2006","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.4049\/jimmunol.167.9.5386","article-title":"Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization","volume":"167","author":"HF Staats","year":"2001","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.4049\/jimmunol.165.11.6454","article-title":"Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL","volume":"165","author":"IM Belyakov","year":"2000","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1128\/JVI.05060-11","article-title":"Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen","volume":"85","author":"N Winstone","year":"2011","journal-title":"Journal of virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2796.2008.02051.x","article-title":"Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6","volume":"265","author":"M Genesca","year":"2009","journal-title":"J Intern Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mi.2013.1","article-title":"Unique IL-13Ralpha2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity","volume":"6","author":"C Ranasinghe","year":"2013","journal-title":"Mucosal Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.4049\/jimmunol.178.4.2370","article-title":"Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine\/granzyme B profiles","volume":"178","author":"C Ranasinghe","year":"2007","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4049\/jimmunol.182.3.1351","article-title":"IL-12 enhances CTL synapse formation and induces self-reactivity","volume":"182","author":"MA Markiewicz","year":"2009","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4049\/jimmunol.181.8.5296","article-title":"Priming of a novel subset of CD28+ rapidly expanding high-avidity effector memory CTL by post maturation electroporation-CD40L dendritic cells is IL-12 dependent","volume":"181","author":"MA DeBenedette","year":"2008","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4049\/jimmunol.180.4.2504","article-title":"Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge","volume":"180","author":"Z Li","year":"2008","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e44778","DOI":"10.1371\/journal.pone.0044778","article-title":"Biologically-directed modeling reflects cytolytic clearance of SIV-infected cells in vivo in macaques","volume":"7","author":"WD Wick","year":"2012","journal-title":"PloS one"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"F Sallusto","year":"1999","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1326","article-title":"Host-reactive CD8+ memory stem cells in graft-versus-host disease","volume":"11","author":"Y Zhang","year":"2005","journal-title":"Nat Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells","volume":"15","author":"L Gattinoni","year":"2009","journal-title":"Nat Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"L Gattinoni","year":"2011","journal-title":"Nat Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e67401","DOI":"10.1371\/journal.pone.0067401","article-title":"T-Bet and Eomes Regulate the Balance between the Effector\/Central Memory T Cells versus Memory Stem Like T Cells","volume":"8","author":"G Li","year":"2013","journal-title":"PloS one"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"ML Precopio","year":"2007","journal-title":"J Exp Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1128\/IAI.73.11.7759-7764.2005","article-title":"Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) population","volume":"73","author":"A Kipnis","year":"2005","journal-title":"Infect Immun"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T10:04:32Z","timestamp":1598263472000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107524"}},"subtitle":[],"editor":[{"given":"Clive M.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,12]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107524","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,12]]}}}